Treatment of Irregular Bleeding in Perimenopause with OCP Contraindication
When combined oral contraceptives are contraindicated in perimenopausal women with irregular bleeding, the levonorgestrel intrauterine system (LNG-IUD) is the preferred first-line treatment, offering both bleeding control and contraception. 1
Management Algorithm
Step 1: Rule Out Pathology First
Before initiating any hormonal treatment, exclude:
- Pregnancy (beta-hCG)
- Thyroid disease (TSH)
- Hyperprolactinemia (prolactin level)
- Endometrial pathology (endometrial biopsy if indicated by age >45 years, risk factors, or failed medical management)
- Structural lesions via transvaginal ultrasound or saline infusion sonohysterography 1
Step 2: Treatment Options When OCPs Are Contraindicated
Primary Recommendation: LNG-IUD
- Most effective for controlling perimenopausal menstrual dysfunction 2
- Provides reliable contraception (still needed until age 50-55)
- Can serve as progestogenic opposition if hormone replacement therapy becomes necessary
- Critical caveat: May initially worsen bleeding in first 3-6 months, but ultimately highly effective for long-term control 2
Alternative Progestin-Only Methods (when LNG-IUD declined or contraindicated):
- Progestin-only pills: Safe with cardiovascular risk factors that contraindicate estrogen 3, 4
- Depot medroxyprogesterone acetate (DMPA): Safe option but may cause irregular bleeding requiring NSAIDs for 5-7 days per bleeding episode 5
- Etonogestrel implant: Effective contraception; bleeding irregularities managed with NSAIDs 5-7 days, or for heavy bleeding consider 10-20 days of low-dose COCs (if not contraindicated) or tranexamic acid 5 days 5
Step 3: Symptomatic Management of Breakthrough Bleeding
For bleeding while using progestin-only methods 5:
- NSAIDs (ibuprofen, mefenamic acid): 5-7 days during bleeding episodes
- Tranexamic acid: 5 days for heavy bleeding with implant users
- Short-course estrogen supplementation: 10-20 days for implant users with heavy bleeding (only if no estrogen contraindications)
Step 4: Surgical Options
If medical management fails, is not tolerated, or significant intracavitary lesions exist 1:
- Endometrial ablation
- Hysterectomy
Key Contraindications to Combined OCPs in Perimenopause
The following are absolute contraindications (U.S. MEC Category 4) that would necessitate alternative approaches 3, 4:
- Age >35 years AND smoking ≥15 cigarettes/day
- Cardiovascular disease: history of stroke, ischemic heart disease, complicated valvular disease
- Venous thromboembolism (current or history)
- Thrombogenic mutations (Factor V Leiden, prothrombin mutation)
- Migraine with aura at any age
- Breast cancer (current)
- Uncontrolled hypertension (≥160/100 mmHg)
- Diabetes with vascular complications
- Active liver disease or liver tumors
Important Clinical Pearls
Age alone is NOT a contraindication to hormonal contraception 3. The decision must be based on individual risk factors, not arbitrary age cutoffs.
Natural estrogens preferred after age 40: If combined hormonal contraception is appropriate (no contraindications), formulations with natural estradiol rather than ethinyl estradiol may have better cardiovascular safety profiles 3.
Contraception still necessary: Even with irregular cycles, pregnancy remains possible and carries higher maternal-fetal risks after age 40. Continue contraception until age 50-55 or confirmed menopause 4, 2.
Reassurance is therapeutic: Irregular bleeding in the first 3 months of any progestin method is expected and normal. Counseling about this expectation improves continuation rates 5, 6.